QIU Lu-gui, ZHOU De-hui, WAN Chang-chun. Risk-Adjusted Therapy of Pediatric and Adolescent Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 284-286. DOI: 10.3969/j.issn.1671-5144.2009.05.015
|
Citation:
|
QIU Lu-gui, ZHOU De-hui, WAN Chang-chun. Risk-Adjusted Therapy of Pediatric and Adolescent Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 284-286. DOI: 10.3969/j.issn.1671-5144.2009.05.015
|
QIU Lu-gui, ZHOU De-hui, WAN Chang-chun. Risk-Adjusted Therapy of Pediatric and Adolescent Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 284-286. DOI: 10.3969/j.issn.1671-5144.2009.05.015
|
Citation:
|
QIU Lu-gui, ZHOU De-hui, WAN Chang-chun. Risk-Adjusted Therapy of Pediatric and Adolescent Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 284-286. DOI: 10.3969/j.issn.1671-5144.2009.05.015
|
DownLoad: